Sei Investments CO Catalyst Pharmaceuticals, Inc. Transaction History

Sei Investments CO

$74.7 Billion
Q3 2024

A detailed history of Sei Investments CO transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Sei Investments CO holds 101,469 shares of CPRX stock, worth $2.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

101,469

Previous 84,458 20.14%

Holding current value

$2.05 Million

Previous $1.31 Million 54.2%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$15.19 - $21.35 $258,397 - $363,184	17,011 Added 20.14%	101,469 $2.02 Million
Q2 2024 Aug 13, 2024	BUY	$14.68 - $16.92 $16,118 - $18,578	1,098 Added 1.32%	84,458 $1.31 Million
Q1 2024 May 07, 2024	BUY	$13.18 - $17.11 $429,944 - $558,145	32,621 Added 64.29%	83,360 $1.33 Million
Q4 2023 Feb 14, 2024	BUY	$11.78 - $17.29 $99,929 - $146,671	8,483 Added 20.08%	50,739 $852,000
Q3 2023 Nov 14, 2023	SELL	$11.69 - $15.02 $37,887 - $48,679	-3,241 Reduced 7.12%	42,256 $493,000
Q2 2023 Aug 11, 2023	SELL	$11.5 - $18.08 $340,860 - $535,891	-29,640 Reduced 39.45%	45,497 $611,000
Q1 2023 May 12, 2023	BUY	$14.34 - $21.05 $418,011 - $613,607	29,150 Added 63.39%	75,137 $1.25 Million
Q4 2022 Feb 10, 2023	SELL	$12.25 - $19.5 $2.12 Million - $3.38 Million	-173,465 Reduced 79.04%	45,987 $855,000
Q3 2022 Nov 14, 2022	SELL	$7.06 - $15.52 $915,780 - $2.01 Million	-129,714 Reduced 37.15%	219,452 $2.82 Million
Q2 2022 Aug 15, 2022	BUY	$6.23 - $8.57 $333,005 - $458,083	53,452 Added 18.08%	349,166 $2.44 Million
Q1 2022 May 13, 2022	BUY	$5.31 - $8.31 $647,129 - $1.01 Million	121,870 Added 70.1%	295,714 $2.45 Million
Q3 2021 Nov 12, 2021	BUY	$4.85 - $6.04 $843,143 - $1.05 Million	173,844 New	173,844 $921,000
Q2 2021 Aug 06, 2021	SELL	$4.29 - $6.05 $81,102 - $114,375	-18,905 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$2.97 - $5.08 $172,791 - $295,549	-58,179 Reduced 75.47%	18,905 $56,000
Q2 2020 Aug 17, 2020	BUY	$3.48 - $5.05 $223,819 - $324,795	64,316 Added 503.73%	77,084 $356,000
Q2 2020 Aug 11, 2020	SELL	$3.48 - $5.05 $223,819 - $324,795	-64,316 Reduced 83.44%	12,768 $48,000
Q1 2020 May 14, 2020	BUY	$2.61 - $5.21 $167,864 - $335,086	64,316 Added 503.73%	77,084 $297,000
Q4 2019 Feb 06, 2020	BUY	$3.67 - $5.7 $46,858 - $72,777	12,768 New	12,768 $48,000
Q2 2019 Aug 14, 2019	SELL	$2.7 - $6.11 $302,856 - $685,352	-112,169 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$2.11 - $5.33 $236,676 - $597,860	112,169 New	112,169 $572,000
Q2 2018 Aug 03, 2018	SELL	$2.26 - $3.84 $2,824 - $4,800	-1,250 Closed	0 $0
Q4 2017 Feb 08, 2018	BUY	$2.51 - $4.4 $3,137 - $5,500	1,250	1,250 $5,000

Others Institutions Holding CPRX

# of Institutions

325

Shares Held

94.1M

Call Options Held

19.1K

Put Options Held

51.1K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.08B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Account

Sei Investments CO Catalyst Pharmaceuticals, Inc. Transaction History